Primary neuroblastomas only rarely display TP53 mutations, whereas relapsed high-risk neuroblastomas frequently show TP53 mutations and loss of p53 function, which are both linked to a poor prognosis [6,7,8,9]. This evidence concerns the gene TP53 and neuroblastoma.